IP Library Patent Application 11445815
Patent Application
App. No. 11/445,815

Detection of target analytes using particles and electrodes

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/445,815
Abstract

The invention relates to the use of particles comprising binding ligands and electron transfer moieties (ETMs). Upon binding of a target analyte, a particle and a reporter composition are associated and transported to an electrode surface. The ETMs are then detected, allowing the presence or absence of the target analyte to be determined.

Claims (28)

1 - 6 . (canceled)

7 . A method of detecting cells using colloid particles, comprising:

a) forming an assay complex on a surface, wherein said assay complex comprises

1) said cells;

2) at least one colloid particle comprising a binding ligand; and

3) at least one signaling moiety that is either directly or indirectly attached to said assay complex; and

b) detecting said cells by detecting said signaling moiety.

8 . A method according to claim 7 , wherein said surface is an electrode.

9 . A method according to claim 7 , wherein said colloid particle is a gold colloid particle.

10 . A method according to claim 7 , wherein said colloid particle further comprises a self-assembled monolayer (SAM).

11 . A method according to claim 10 , wherein said SAM is a mixed SAM comprising a at least two species of molecules.

12 . A method according to claim 10 , wherein said binding ligand is attached to said SAM via a transitional metal ligand.

13 . A method according to claim 12 , wherein said transitional metal ligand comprises nickel.

14 . A method according to any of claims 7 to 13 , wherein said binding ligand is a protein.

15 . A method according to claim 7 , wherein said signaling moiety is an electron transfer moiety (ETM).

16 . A method according to claim 7 , wherein said signaling moiety is a fluorescent moiety.

17 . A composition comprising a colloid particle comprising:

1) at least one signaling moiety; and

2) a mixed self-assembled monolayer (SAM), wherein said SAM comprises at least two species of molecules.

18 . A composition according to claim 17 , wherein one of said species of molecules comprises a protein.

19 . A composition according to claim 17 , wherein one of said species of molecule comprises an insulator.

20 . A composition according to claim 19 , wherein said insulator comprises an alkyl or a heteroalkyl oligomer.

21 . A composition according to claim 17 , wherein said signaling moiety comprises an electron transfer moiety (ETM).

22 . A composition comprising a colloid particle comprising:

a) a self-assembled monolayer (SAM); and

b) a non-DNA binding ligand attached to said colloid particle.

23 . A composition according to claim 22 , wherein said binding ligand comprises a protein.

24 . A composition according to claim 23 , wherein said protein is a peptide.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 18, 2021
From: GENMARK DIAGNOSTICS, INC.
To: ROCHE MOLECULAR SYSTEMS, INC.
Reel/Frame 058189/0563 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2009
From: CLINICAL MICRO SENSORS, INC., DBA OSMETECH MOLECULAR DIAGNOSTICS
To: OSMETECH TECHNOLOGY INC.
Reel/Frame 022378/0868 →